IA
IOVA icon

IFP Advisors’s Iovance Biotherapeutics IOVA Stock Holding History

IFP Advisors’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.7K Buy
1,611
+1,495
+1,289% +$5.68K ﹤0.01% 3606
2026
Q1 		$407 Buy
116
+65
+127% +$208 ﹤0.01% 4466
2025
Q4 		$139 Sell
51
-25
-33% -$58 ﹤0.01% 4543
2025
Q3 		$165 Sell
76
-12
-14% -$28 ﹤0.01% 4431
2025
Q2 		$151 Buy
+88
New +$219 ﹤0.01% 4683
2025
Q1 		– Hold
0
– – – 4232
2024
Q4 		– Hold
0
– – – 4437
2023
Q3 		– Sell
-300
Closed -$2.11K – 3438
2023
Q2 		$2.11K Buy
+300
New +$2.15K ﹤0.01% 2861
2023
Q1 		– Sell
-1,235
Closed -$18K – 3910
2022
Q4 		$18K Sell
1,235
-48
-4% -$375 ﹤0.01% 2972
2022
Q3 		$18K Buy
1,283
+1,100
+601% +$12.7K ﹤0.01% 3188
2022
Q2 		$2K Hold
183
– – ﹤0.01% 4136
2022
Q1 		$2K Buy
+183
New +$2.83K ﹤0.01% 4134
2021
Q4 		– Sell
-49
Closed -$1K – 3420
2021
Q3 		$1K Buy
+49
New +$1.16K ﹤0.01% 3044
2021
Q2 		– Sell
-4
Closed -$104 – 3144
2021
Q1 		$0 Sell
4
-61
-94% -$2.53K ﹤0.01% 3108
2020
Q4 		$3K Buy
65
+50
+333% +$1.99K ﹤0.01% 2510
2020
Q3 		$0 Buy
+15
New +$460 ﹤0.01% 2922

Other funds holding IOVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

IFP Advisors's IOVA Position: Q2 2026 in Review

IFP Advisors increased its Iovance Biotherapeutics (IOVA) stake by 1,289% in Q2 2026, buying an estimated $5.68K and bringing the position to 1,611 shares worth $6.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3606.

IFP Advisors first reported a position in IOVA in Q3 2020 and has held it in 14 quarters since. The position peaked at $18K in Q4 2022. 292 funds tracked by Wall St. Rank hold IOVA as of Q2 2026.

  • IFP Advisors held 1,611 shares of Iovance Biotherapeutics worth $6.7K as of Q2 2026.
  • IFP Advisors bought 1,495 Iovance Biotherapeutics shares in Q2 2026, an estimated $5.68K.
  • Iovance Biotherapeutics made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #3606 holding.
  • IFP Advisors first reported a position in Iovance Biotherapeutics in Q3 2020 and has held it in 14 quarters since.
  • IFP Advisors's Iovance Biotherapeutics position peaked at $18K in Q4 2022.
  • 292 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.